Armata Pharmaceuticals (ARMP) EPS (Basic): 2013-2024
Historic EPS (Basic) for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to -$0.52.
- Armata Pharmaceuticals' EPS (Basic) fell 500.00% to -$0.24 in Q4 2018 from the same period last year, while for Dec 2018 it was -$2.96, marking a year-over-year increase of 9.76%. This contributed to the annual value of -$0.52 for FY2024, which is 72.77% up from last year.
- According to the latest figures from FY2024, Armata Pharmaceuticals' EPS (Basic) is -$0.52, which was up 72.77% from -$1.91 recorded in FY2023.
- Over the past 5 years, Armata Pharmaceuticals' EPS (Basic) peaked at -$0.52 during FY2024, and registered a low of -$1.91 during FY2023.
- For the 3-year period, Armata Pharmaceuticals' EPS (Basic) averaged around -$1.17, with its median value being -$1.08 (2022).
- Its EPS (Basic) has fluctuated over the past 5 years, first crashed by 76.85% in 2023, then spiked by 72.77% in 2024.
- Armata Pharmaceuticals' EPS (Basic) (Yearly) stood at -$1.35 in 2020, then climbed by 28.89% to -$0.96 in 2021, then declined by 12.50% to -$1.08 in 2022, then tumbled by 76.85% to -$1.91 in 2023, then spiked by 72.77% to -$0.52 in 2024.